ATENOLOL 50 MG TABLET
For 30 tablets
Pharmacies pay
$0.71 filed
30 × $0.0236 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$2.64 filed
30 × $0.08799 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
3.7× estimated
Medicare paid 3.7× what pharmacies pay.
Part D averages every strength and form sold under “Atenolol” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$5.82 estimated
$0.71 + $0.11 (15%) + $5.00 fee per fill = $5.82
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23, 2026-09-30 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
ATENOLOL 50 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as atenolol.
FDA gives its dosage form as tablet and its route as oral.
FDA lists 8 labelers (the companies named on the label) for its NDCs, among them Teva Pharmaceuticals USA, Inc., Mylan Pharmaceuticals Inc. and Unichem Pharmaceuticals (USA), Inc.
FDA’s Established Pharmacologic Class for it is beta-Adrenergic Blocker.
The NADAC file of 2026-10-14 prices it under 17 NDCs (National Drug Codes); the FDA directory lists 15 of them.
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $0.71 for 30 tablets (30 × $0.0236 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; those prices took effect between 2026-09-23 and 2026-09-30. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 tablets · NADAC explanation codes
The 8 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Unichem Pharmaceuticals (USA), Inc. | 3 | $0.0236 per EA filed |
| Aurobindo Pharma Limited | 2 | $0.0236 per EA filed |
| Mylan Pharmaceuticals Inc. | 2 | $0.0236 per EA filed |
| Rising Pharma Holdings, Inc. | 2 | $0.0236 per EA filed |
| Teva Pharmaceuticals USA, Inc. | 2 | $0.0236 per EA filed |
| Zydus Pharmaceuticals USA Inc. | 2 | $0.0236 per EA filed |
| Ipca Laboratories Limited | 1 | $0.0236 per EA filed |
| Mylan Institutional Inc. | 1 | $0.0236 per EA filed |
| Not listed as a package in the FDA directory | 2 | $0.0236 per EA filed |
When these prices took effect
- 2026-09-30 · 1 NDC · $0.0236 per EA filed
- 2026-09-23 · 16 NDCs · $0.0236 per EA filed
All 17 NDCs, with labeler and price
- 00093-0752-01 · Teva Pharmaceuticals USA, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 00093-0752-10 · Teva Pharmaceuticals USA, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 00378-0231-01 · Mylan Pharmaceuticals Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 00378-0231-10 · Mylan Pharmaceuticals Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 29300-0411-01 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 29300-0411-05 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 29300-0411-10 · Unichem Pharmaceuticals (USA), Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 51079-0684-01 · not listed as a package in the FDA directory · $0.0236 per EA · eff. 2026-09-23 filed
- 51079-0684-20 · Mylan Institutional Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 64980-0438-01 · Rising Pharma Holdings, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 64980-0438-10 · Rising Pharma Holdings, Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 65862-0169-01 · Aurobindo Pharma Limited · $0.0236 per EA · eff. 2026-09-23 filed
- 65862-0169-99 · Aurobindo Pharma Limited · $0.0236 per EA · eff. 2026-09-23 filed
- 68382-0023-01 · Zydus Pharmaceuticals USA Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 68382-0023-10 · Zydus Pharmaceuticals USA Inc. · $0.0236 per EA · eff. 2026-09-23 filed
- 75834-0282-00 · not listed as a package in the FDA directory · $0.0236 per EA · eff. 2026-09-23 filed
- 83980-0023-01 · Ipca Laboratories Limited · $0.0236 per EA · eff. 2026-09-30 filed
Other strengths, forms and brands
3 other products in the NADAC file share the FDA nonproprietary name atenolol with ATENOLOL 50 MG TABLET.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| ATENOLOL 25 MG TABLET | $0.02171 per EA filed | $0.08799 per EA filed |
| ATENOLOL 50 MG TABLET this page | $0.0236 per EA filed | $0.08799 per EA filed |
| ATENOLOL 100 MG TABLET | $0.03614 per EA filed | $0.08799 per EA filed |
| TENORMIN 50 MG TABLET | $12.7821 per EA filed | $12.56706 per EA filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-09-30 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 17 NDCs’ NADAC prices is $0.0236 per EA filed.
Of the 76 other products in FDA’s beta-Adrenergic Blocker class priced per EA, 70 have a higher middle NADAC price and 6 a lower one. The one in the middle is NADOLOL 40 MG TABLET, at $0.26544 per EA filed (eff. 2026-09-23).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $2.64 for 30 tablets, at an average of $0.08799 per EA in 2024 (2024-01-01 to 2024-12-31) for “Atenolol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 6,459,376 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 tablets? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for ATENOLOL 50 MG TABLET labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Atenolol / Atenolol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- METOPROLOL SUCC ER 100 MG TAB
- METOPROLOL TARTRATE 100 MG TAB
- CARVEDILOL 12.5 MG TABLET
- PROPRANOLOL 10 MG TABLET
- TIMOLOL 0.25% GEL-SOLUTION